.svg){kind=small}
Dilshat Djumanov MPhil, PhD
Director of Data Science
Dilshat has an in depth knowledge of data management and data analysis for adaptive clinical trials and QTc studies. Dilshat has a background in IT and demonstrable knowledge of process automation and improvement.
Having worked at Richmond Pharmacology for 14 years, he has led pioneering software development projects which have ensured Richmond Pharmacology’s data management and other processes are efficient, transparent and fast.
Dilshat’s experience is backed by his academic achievements, including a MSc in Computer Sciences, a MPhil in Medical Engineering and a PhD in Computational Fluid Dynamics.
-min.jpg)
.jpg)
Latest news
Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease
June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read moreA first of a kind trial in the fight against malaria
June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read moreEvents
AHA Hypertension Scientific Sessions 2024
5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event
